Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

With all doses of FDA-approved Wegovy ® fully available nationwide ... permitted to manufacture "semaglutide" for use in drugs in China. However, they are exporting this "semaglutide" into ...

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...

FDA-approved Wegovy ® (semaglutide) injection 2.4 mg. As the company's efforts to safeguard patients from the dangers of illicit and illegal compounded "semaglutide" continues, a one-time offer ...

China is now one step closer to joining the boom in weight-loss drugs. The country's health officials approved the popular weight loss drug Wegovy, its manufacturer Novo Nordisk said on Tuesday.

Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

The portfolio continues to invest in companies we believe are strong and improving and have improvement that is sustainable.